SCHEMBL7213023

SCHEMBL7213023

O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1NS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A6 Q3KNW5 2/20 0.73
SLC10A2 Q12908 1/20 0.73
SLC10A1 Q14973 1/20 0.73
GPR27 Q9NS67 9/20 0.63
AVPR2 P30518 2/20 0.63
KDM1A O60341 1/20 0.57
METAP2 P50579 2/20 0.55
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
POLB P06746 2/20 0.52
PSMD14 O00487 1/20 0.52
FGB P02675 1/20 0.52
MAPT P10636 1/20 0.52
CACNA1B Q00975 1/20 0.52
APBA1 Q02410 1/20 0.52
PLEC Q15149 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
STING1 Q86WV6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7120319 0.93 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7116008 0.92 SLC10A6 (0.85) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7213183 0.89 SLC10A6 (0.73) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7208175 0.88 SLC10A6 (0.69) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7208171 0.88 SLC10A6 (0.69) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7126120 0.86 SLC10A6 (0.98) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7208184 0.86 SLC10A6 (0.76) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7626967 0.85 SLC10A6 (0.68) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL6756862 0.84 SLC10A6 (1.00) SLC10A6SLC10A2SLC10A1GPR27AVPR2
SCHEMBL7213211 0.83 GPR27 (0.67) SLC10A6SLC10A2SLC10A1GPR27AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed